• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream

    8/20/25 7:00:00 AM ET
    $ADVM
    $CLNN
    $DERM
    $EHGO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 – Presenting Today, August 20, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Immuron Limited (NASDAQ:IMRN)

    Keynote speaker: Steve Lydeamore, CEO

    9:40 – 10:10

    Nutriband, Inc. (NASDAQ:NTRB)

    Keynote speaker: Serguei Melnik, Founder and President

    10:50 – 11:20

    Metaguest.ai Inc. (OTCQB:MGSTF) (CSE:METG)

    Keynote speaker: Colin Keddy, President

    11:25 – 11:55

    Kelly+Partners (OTCQX:KPGHF) (ASX: KPG)

    Keynote speaker: Brett Kelly, Founder, Executive Chairman & CEO

    12:35 – 1:05

    Journey Medical Corporation (NASDAQ:DERM)

    Keynote speaker: Claude Maraoui - Founder, President, CEO & Director

    1:10 – 1:40

    22nd Century Group, Inc. (NASDAQ:XXII)

    Keynote speaker: Lawrence D. Firestone, Chairman & CEO

    1:45 – 2:15

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:20 – 2:50

    Clene Inc., (NASDAQ:CLNN)

    Keynote speakers: Rob Etherington, President / CEO

    2:55 – 3:05

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    3:10 – 3:20

    HeartSciences, Inc. (NASDAQ:HSCS)

    Keynote speaker: Andrew Simpson, President / CEO

    Postponed to September 24

    Adverum Biotechnologies (NASDAQ:ADVM)

    Keynote speaker: Jason Awe, PhD, MBA, Corporate Communications & IR

    3:40 – 3:50

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    3:55 – 4:05

    BitFuFu Inc. (NASDAQ:FUFU)

    Keynote speaker: Charley Brady, VP Investor Relations

    4:10 – 4:20

    Impact Minerals Limited, (ASX: IPT)

    Keynote speaker: Dr. Mike Jones, Managing Director

    4:25 – 4:35

    Zyppah, a Private Company

    Keynote speaker: Dr. Jonathan Greenburg, founder and owner, & Larry Biggs, CEO

    4:40 – 4:50

    Ucore Rare Metals, Inc. (OTCQX:UURAF) (TSXV:UCU)

    Keynote speakers: Pat Ryan, CEO

    _______________________________________________________________

    Day 2 – Presenting Tomorrow, August 21, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Eshallgo, Inc. (NASDAQ:EHGO)

    Keynote speakers: Johnny Wu, President

    10:15 – 10:45

    Terra Clean Energy (OTCQB:TCEFF) (CSE:TCEC)

    Keynote speaker: Greg Cameron, CEO

    10:50 – 11:20

    Grove Collaborative Holdings, Inc. (NYSE:GROV)

    Keynote speakers: Jeff Yurcisin, CEO & Tom Siragusa, Interim CFO

    11:25 – 11:55

    Phoenix Energy Services Corp., (OTCQB:PHXHF) (TSE: PHX)

    Keynote speaker: Mike Buker, President and CEO

    12:00 – 12:30

    Vista Gold Corp. (NYSE:VGZ) (TSX:VGZ)

    Keynote speaker: Frederick Earnest, CEO

    12:35 – 1:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Chris Holden – VP Corporate Development

    1:10 – 1:40

    Kobo Resources, Inc. (OTCQB:KBRIF) (TSXV:KRI)

    Keynote speakers: Edouard Gosselin, Director, CEO and Corporate Secretary & Paul Sarjeant, Director, President and COO

    1:45 – 2:15

    Puma Exploration Inc. (TSXV:PUMA) (OTCQB:PUMXF)

    Marcel Robillard, CEO & President

    2:20 – 2:50

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    2:55 – 3:05

    Highland Copper Company Inc. (OTCQB:HDRSF) (TSXV:HI)

    Keynote speaker: Barry O'Shea, CEO

    3:10 - 3:20

    Odyssey Marine Exploration, Inc. (NASDAQ:OMEX)

    Keynote speaker: Mark D. Gordon, Chairman & CEO

    3:25 – 3:35

    C3 Metals Inc. (TSXV:CCCM) (OTCQB:CUAUF)

    Keynote speaker: Daniel A. Symons, President, CEO & Director

    3:40 – 3:50

    Lahontan Gold Corp. (TSXV:LG) (OTCQB:LGCXF)

    Keynote speaker: Kimberly Ann, President / CEO

    3:55 – 4:05

    Opawica Explorations Inc. (OTCQB:OPWEF) (TSXV:OPW)

    Keynote speaker: Blake Morgan, President / CEO

    4:10 – 4:20

    Vizsla Royalties Corp. (TSXV:VROY) (OTCQB:VROYF)

    Keynote speaker: Michael N. Pettingell, President and CEO

    4:25 – 4:35

    Star Gold Corp. (OTCQB:SRGZ)

    Keynote speaker: Lindsay E. Gorrill, Chairman & CEO

    4:40 – 4:50

    NCS Multistage Holdings, Inc. (NASDAQ:NCSM)

    Keynote speaker: Ryan Hummer, CEO & Director

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $CLNN
    $DERM
    $EHGO

    CompanyDatePrice TargetRatingAnalyst
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    Journey Medical Corporation
    $DERM
    8/25/2025$13.00Buy
    H.C. Wainwright
    BitFuFu Inc.
    $FUFU
    8/13/2025$6.00Buy
    Roth Capital
    Journey Medical Corporation
    $DERM
    7/30/2025$12.00Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    7/18/2025Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    6/18/2025$5.50Market Perform
    Northland Capital
    Grove Collaborative Holdings Inc.
    $GROV
    5/15/2025$1.20Outperform → Market Perform
    Telsey Advisory Group
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    More analyst ratings

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, PRESIDENT AND DIRECTOR Fischer Laurent bought $553,917 worth of shares (128,699 units at $4.30), increasing direct ownership by 177% to 201,513 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:06 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CHIEF OPERATING OFFICER Soparkar Peter bought $211,000 worth of shares (50,000 units at $4.22), increasing direct ownership by 166% to 80,189 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:04 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CEO Smith Ryan Lewis bought $4,560 worth of shares (4,000 units at $1.14), increasing direct ownership by 0.34% to 1,183,039 units (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    9/15/25 7:00:12 AM ET
    $USEG
    Oil & Gas Production
    Energy

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Odyssey Marine Exploration's Unsolicited Request for a U.S. Offshore Mineral Lease Sale Advances as BOEM Initiates Formal Review Process

    A year of policy alignment, project advancement, and balance-sheet strengthening sets the stage for continued progress in 2026 Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a U.S.-based ocean exploration and marine resource development leader, received news that the Bureau of Ocean Energy Management's (BOEM), a department of the U.S. Department of Interior (DOI) has initiated the formal review process for its unsolicited request for a potential marine mineral lease sale in federal waters offshore Virginia. "BOEM's decision to initiate this process is an important step toward responsibly evaluating the mineral potential of the U.S. Outer Continental Shelf," said Mark Gordon, Chairman and

    12/15/25 8:30:00 AM ET
    $GLDD
    $OMEX
    Military/Government/Technical
    Industrials
    Marine Transportation
    Consumer Discretionary

    HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

    Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc.  (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company advancing the use of ECG/EKGs through the integration of artificial intelligence ("AI"), today announced it has submitted its MyoVista® wavECG™ device to the U.S. Food and Drug Administration ("FDA") for 510(k) premarket clearance. The MyoVista wavECG device is designed to provide conventional ECG functionality while serving as a platform capable of hosting AI-ECG algorithm(s). Following the recent publication of updated American Society of Echocardiography ("ASE") guidelines for the assessment of Left Ventricula

    12/15/25 8:30:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    BitFuFu Named to World Future Awards' TOP 100 Next Generation Companies for 2025

    SINGAPORE, Dec. 12, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, has been named one of the World Future Awards' TOP 100 Next Generation Companies of 2025, a global honor recognizing organizations shaping the future through excellence, innovation, and positive impact. In an official congratulatory letter issued by the World Future Awards Organizing Committee, the panel commended BitFuFu for its "dedication to innovation and excellence,". They added that the Company "embodies the highest standards of creativity, effectiveness, and influence in shaping the future of its field." The TOP 100 Ne

    12/12/25 8:15:00 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    $ADVM
    $CLNN
    $DERM
    $EHGO
    SEC Filings

    View All

    SEC Form 6-K filed by Immuron Limited

    6-K - Immuron Ltd (0001660046) (Filer)

    12/15/25 6:32:02 AM ET
    $IMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-1 filed by GeoVax Labs Inc.

    S-1 - GeoVax Labs, Inc. (0000832489) (Filer)

    12/12/25 5:26:42 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Jaguar Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Jaguar Health, Inc. (0001585608) (Filer)

    12/12/25 4:46:54 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Leadership Updates

    Live Leadership Updates

    View All

    BitFuFu to Update Investors at the Emerging Growth Conference on December 11, 2025

    SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that it will provide a brief update to investors at the Emerging Growth Conference on December 11, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Vice President of Investor Relations, Charley Brady, who will present an update and, time permitting, open the floor for questions. Please submit your questions in advance to [email protected] or ask your questions during the event. BitFuFu will be presenti

    12/9/25 11:00:00 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

    ORLANDO, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (the "Company") is pleased to announce that it has been invited to present on the Emerging Growth Conference on August 20, 2025. The next Emerging Growth Conference is presenting on August 20, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Chairman, Serguei Melnik in real time. Mr. Melnik will perform a presentation and may subsequently open the floor for questions. Please submit your questions in advance to [email protected] or ask your questions during the event and Mr. Melnik will do his best to

    8/18/25 9:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, PRESIDENT AND DIRECTOR Fischer Laurent exercised 150,000 shares at a strike of $4.20 and was granted 500,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/10/25 1:52:31 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CHIEF OPERATING OFFICER Soparkar Peter was granted 150,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/10/25 1:49:41 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Medical Officer Ozden Rabia Gurses was granted 85,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/10/25 1:46:33 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Adverum Biotech downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adverum Biotech from Buy to Neutral

    11/17/25 9:39:07 AM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    H.C. Wainwright initiated coverage on Journey Medical with a new price target

    H.C. Wainwright initiated coverage of Journey Medical with a rating of Buy and set a new price target of $13.00

    8/25/25 8:12:40 AM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Roth Capital initiated coverage on BitFuFu with a new price target

    Roth Capital initiated coverage of BitFuFu with a rating of Buy and set a new price target of $6.00

    8/13/25 8:06:38 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    $ADVM
    $CLNN
    $DERM
    $EHGO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Financials

    Live finance-specific insights

    View All

    Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8®

    FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8Biomarker improvements are strongly associated with longer survival, reinforcing CNM-Au8's potential disease modifying activityCompany has requested a Type C meeting in the first quarter of 2026 to present the newly completed analyses supporting a planned NDA submission under the accelerated approval pathwayClene is hosting an investor webcast today at 8:30 am ET SALT LAKE CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene" or the "Company") and its wholly owned subsidiary Clene Nanomedicine, Inc., a late clinic

    12/3/25 8:00:00 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Grove Announces Third Quarter 2025 Financial Results

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or the "Company"), the world's first plastic neutral retailer and a leading sustainable consumer products company, certified B Corporation, and Public Benefit Corporation, today reported financial results for its fiscal third quarter ended September 30, 2025. Key Financial Highlights: (comparison vs prior year unless otherwise noted) Total Revenue was $43.7 million, down 9.4% year-over-year; down 0.7% versus Q2 Net Loss of $3.0 million, compared to Net Loss of $1.3 million in same period last year Adjusted EBITDA loss of $1.2 million, compared to breakeven in same period last year Executed a reduction in force in November

    11/13/25 4:10:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    Vista Gold Highlights Mt Todd Milestones and Announces Third Quarter 2025 Financial Results

    Vista Gold Corp. (NYSE American and TSX:VGZ) today announced its unaudited financial results for the quarter ended September 30, 2025, with cash totaling $13.7 million at quarter-end. All dollar amounts in this press release are in U.S. dollars. Frederick H. Earnest, President and CEO of Vista, said, "In the third quarter, Vista completed a feasibility study for Mt Todd that presents a fresh vision for the project as a 15,000 tonne per day operation – one that prioritizes lower initial capital costs and higher ore grades. It also incorporates proven Australian design and operating practices that reduce risk, simplify construction, and support long-term operational success over a 30-year m

    11/12/25 5:07:00 PM ET
    $VGZ
    Precious Metals
    Basic Materials

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Journey Medical Corporation

    SC 13G - Journey Medical Corp (0001867066) (Subject)

    11/29/24 2:00:25 PM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:57:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care